Eevia Health Plc is exhibiting at the Supply Side West trade show in Las Vegas, US November 1-4, 2022, with a sharper competitive stance

Eevia Health is presenting its branded ingredients at a major trade show for the nutraceutical industry, SupplySide West, which takes place in Las Vegas, USA this week. This trade show is co-organized with Food ingredients North America and is the premier gathering of health & nutrition professionals bringing together buyers and suppliers from throughout the industry. SupplySide events are all about the science and strategy around the development of products driving the global business economy. 



Eevia Health will issue new shares in a preferential rights issue of 21.6 MSEK

The Board of Directors of Eevia Health Plc ("Eevia" or the "Company") has today decided on a rights issue with preferential rights for Eevia's existing shareholders ("Rights Issue"). The target amount is approximately SEK 21.6 million. The proceeds shall primarily finance sales and marketing efforts and increase working capital. About 82 percent of the Rights Issue is covered by subscription and guarantee commitments.


Eevia Health Plc receives a 934 KSEK / 85 KEUR sales order for a Bilberry extract product

Following a successful quality audit by Eevia Health Plc's ("Eevia" or "The Company") French auditor Natural Ingredients, Eevia has received an 85 KEUR sales order for Bilberry extract from its distributor.


Eevia Health Plc receives a 220 SEK / 20 KEUR sales order for a Bilberry extract

Eevia Health Plc, ("Eevia" or "The Company"), has received a 20 KEUR sales order from a new Finnish customer.


Eevia Health Plc receives a 1 MSEK/96 KEUR sales order for a Bilberry extract product

Eevia Health Plc, ("Eevia" or "The Company"), has received a 96 KEUR sales order from a European nutraceutical brand owner.


Eevia welcomes Dr. Tommi Kilpeläinen as Scientific Product Manager

Eevia Health Plc ("Eevia" or "The Company") is welcoming Dr. Tommi Kilpeläinen asits new Scientific Product Manager.


Communique from the Extraordinary General Meeting of Shareholders in Eevia Health Plc

The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on October 11, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:

Authorizing the Board of Directors to decide on the issuance of shares, options, and other special rights


Notice to the Extraordinary General Meeting of Eevia Health Abp

Notice is given to the shareholders of Eevia Health Abp (Plc) to the Extraordinary General Meeting to be held on 11 October 2022 at 12:00 (Finnish time GMT +3) at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland.

The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11:00.


Eevia Health Plc receives starting sales orders from new Asian customers

Eevia Health Plc, ("Eevia" or "The Company"), has received two small starting sales orders from South Korea and Taiwan, totaling approx. 24 KEUR for organically certified bilberry extracts.


Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted